Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles

Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles
复制标题

Pep-1 修饰的超顺磁性氧化铁/PTX 负载聚合物纳米粒子的增强抗肿瘤作用

DOI:
10.3389/fphar.2018.01556
复制
发表时间:
2019-01-22
影响因子:
5.6
通讯作者:
Xin, Hongliang
Xin, Hongliang
中科院分区:
医学2区
文献类型:
--
作者:
Wang, Baoyan;Wu, Weijun;Xin, Hongliang

文献摘要

被引文献

相似文献

超顺磁性氧化铁纳米粒子(SPION)由于其独特的性质,在药物传递领域得到了广泛的关注。在本研究中,我们开发了紫杉醇(PTX)和SPION共载PLGA纳米粒,修饰Pep-1肽(Pep-NP-SPION/PTX)的双重靶向给药系统,以实现肿瘤治疗的磁靶向和主动靶向。采用共沉淀法合成SPION,并将其与紫杉醇(PTX)同时包封于PLGA纳米粒中。然后,通过化学修饰将非复合物与Pep-1偶联。所得Pep-NP-SPION/PTX显示球形形态和IOOnm的平均尺寸。通过体外细胞实验证明Pep-NP-SPION的细胞摄取增强。Pep-NP-SPION/PTX和NP-SPION/PTX的IC 50值分别测定为10.2和19.4 μ g/mL。生物分布研究表明,与非靶向纳米复合物相比,Pep-NP-SPION在肿瘤中的蓄积明显更高。此外,在磁场条件下,NP-SPION和Pep-NP-SPION都表现出更高的肿瘤分布。此外,Pep-NP-SPION/PTX基于主动靶向和磁性靶向特性呈现出期望的体内抗肿瘤效果。总之,Pep-NP-SPION/PTX可以提供磁性靶向和受体介导的靶向以增强抗肿瘤结果。
Superparamagnetic iron-oxide nanoparticle (SPION) has gained tremendous attention for drug delivery applications due to their unique properties. In this study, we developed a dual targeted delivery system with paclitaxel (PTX) and SPION co-loaded PLGA nanoparticles, modified with Pep-1 peptide (Pep-NP-SPION/PTX), to achieve magnetic targeting and active targeting for tumor treatment. SPION was synthesized by a co-precipitation method and was then encapsulated with PTX simultaneously into PLGA nanoparticles. After that, the non-complex was conjugated with Pep-1 through chemical modification. The resulting Pep-NP-SPION/PTX showed a spherical morphology and an average size of 100 nm. The enhancement cellular uptake of Pep-NP-SPION was demonstrated in in vitro through cell experiments. The IC50 value of Pep-NP-SPION/PTX and NP-SPION/PTX was determined to be 10.2 and 19.4 mu g/mL, respectively. A biodistribution study showed that obvious higher accumulations of Pep-NP-SPION was observed in tumors, compared with that of non-targeting nanocomposites. Moreover, under the condition of a magnetic field, both NP-SPION and Pep-NP-SPION exhibited much higher tumor distribution. Furthermore, Pep-NP-SPION/PTX presented desirable in vivo anti-tumor effects based on active targeting and magnetic targeting characteristics. Altogether, Pep-NP-SPION/PTX can offer magnetic targeting and receptor mediated targeting to enhance the anti-tumor outcome.